Ensemble Modeling of Multimodal Electrocardiogram and Echocardiogram Data Improves Quantitative Assessment of Right Ventricular Function.

Autor: Duong SQ; Mount Sinai Kravis Children's Heart Center, The Mount Sinai Hospital, New York, New York, USA.; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Dominy CL; Mount Sinai Kravis Children's Heart Center, The Mount Sinai Hospital, New York, New York, USA., Lampert J; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Singh S; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Croft L; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Zaidi AN; Mount Sinai Kravis Children's Heart Center, The Mount Sinai Hospital, New York, New York, USA.; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Lerakis S; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Goldman ME; The Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York City, New York, USA., Vaid A; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Nadkarni GN; Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jazyk: angličtina
Zdroj: JACC. Advances [JACC Adv] 2024 Aug 21; Vol. 3 (9), pp. 101186. Date of Electronic Publication: 2024 Aug 21 (Print Publication: 2024).
DOI: 10.1016/j.jacadv.2024.101186
Abstrakt: Competing Interests: This study was approved by the Icahn School of Medicine Institutional Review Board. This work was supported by 10.13039/100000050NHLBI R01HL167050-02 (GNN). Dr Nadkarni has consultancy agreements with Renalytix and Heart Test Laboratories; has received research funding from Renalytix and Heart Test Laboratories; has received honoraria from Lexicon, Daiichi Sankyo, Menarini Health and Reata; has patents or royalties with Renalytix and Heart Test Laboratories; owns equity and stock options in Heart Test Laboratories and Renalytix; owns equity in Verici Dx; has received financial compensation as a scientific board member and advisor to Renalytix and Heart Test Laboratories; and serves in an advisory or leadership role for Pensieve Health and Renalytix. Grant support from ASE Foundation EDGES grant (SQD), United States. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Databáze: MEDLINE